ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Increased Incidence of Clostridium difficile Infections with Proton Pump Inhibitor Use Post-Kidney Transplant.

    M. Spinner,1 K. Patel,1 E. Neuner,1 B. Stephany.2

    1Department of Pharmacy, Cleveland Clinic, Cleveland, OH; 2Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH.

    Clostridium difficile infection (CDI) is often encountered in the solid-organ transplant patient population. The incidence in kidney transplant recipients ranges between 3.5-16%. There are CDI…
  • 2016 American Transplant Congress

    Tacrolimus Dosing, Trough Concentrations and Dose Adjustments Compared Between Two Generic Formulations in Adult Kidney Transplant Recipients.

    D. Taber, V. Phan, A. Wilton, N. Pilch, H. Meadows, J. Fleming, C. Mardis, A. Mardis, C. Bratton, K. Chavin, J. McGillicuddy, S. Nadig, P. Baliga.

    MUSC, Charleston, SC.

    Objective: The aim of this study was to assess if changing between two different formulations of generic tacrolimus ([tac] Mylan® and Dr. Reddy's Lab®) impacts…
  • 2016 American Transplant Congress

    Schisandra Sphenanthera Extract Facilitates Anti-Tuberculosis Treatment Post Renal Transplantation Through Increasing Bioavailability of Tacrolimus.

    R. Deng,1 L. Zhang,1 L. Liu,1 H. Fu,2 J. Li,1 Q. Fu,1 C. Wang.1

    1Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; 2Infectious Medicine Department, Guangzhou Infectious Disease Hospital, Guangzhou, China.

    Background: Hepatoprotective agent Schisandra sphenanthera extract (SchE) facilitates rifampicin-containing anti-tuberculosis (TB) chemotherapy by stabilizing the Tacrolimus (FK506) blood concentration through increasing the oral bioavailability, which…
  • 2016 American Transplant Congress

    Differences in Reported Barriers to Immunosuppression Adherence Among a Cohort of Pediatric Renal Transplant Recipients from the United States and Canada.

    O. Bignall II,1,2 A. Pai,2 S. Amaral,3 S. Furth,3 N. Bergman,2 J. Goebel,4 The TAKE-IT Study Investigators, B. Foster.5

    1Nephrology and Hypertension, Cincinnati Children's Hospital, Cincinnati, OH; 2Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital, Cincinnati, OH; 3Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA; 4Nephrology, Children's Hospital of Colorado, Aurora, CO; 5Nephrology, Montreal Children's Hospital, Montreal, QC, Canada.

    Aim: The purpose of this study was to examine differences in reported barriers to immunosuppressant adherence (IA) between a cohort of pediatric renal transplant recipients…
  • 2016 American Transplant Congress

    Experience of Short-Term Preemptive Treatment for Cytomegalovirus Infection in Seropositive Patients After Liver Transplantation – Ten Years Result of a Single Institution.

    T.-J. Wu, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, R.-S. Soong, C.-F. Lee, H.-S. Chou, K.-M. Chan, W.-C. Lee.

    Division of Liver and Transplantation Surgery, Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.

    Background/purpose Cytomegalovirus (CMV) infection remains a challenge following liver transplantation. Preemptive treatment is an effective strategy for CMV infection. This report shares the ten years'…
  • 2016 American Transplant Congress

    Transplant Specialized Community Pharmacists' Role in Care Transitions for Transplant Patients.

    D. Nguyen,1,2 N. Rickles,2 C. Rogers,3 K. Richards,3 J. Thomas,1 A. Loring,1 H. Kirkham,1 M. Kang,1 K. Poliskey.1

    1Pharmacy, Walgreens Co., Boston, MA; 2Pharmacy, Northeastern University School of Pharmacy, Boston, MA; 3Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA.

    Purpose:In 2004, the United Network for Organ Sharing (UNOS) bylaws recognized pharmacists as an essential part of the patient care team. Recently, the demand for…
  • 2016 American Transplant Congress

    Use of the Psychosocial Assessment Tool to Identify Risk in Families of Pediatric Liver Transplant Recipients.

    E. Fredericks, T. Smith, J. Sevecke, S. Eder, C. Limke, C. Shneider, M. Lopez.

    Pediatrics, University of Michigan, Ann Arbor, MI.

    Purpose: Although families of pediatric liver transplant recipients have documented psychosocial needs, the systematic identification of needs and delivery of evidence-based care remain challenging. This…
  • 2016 American Transplant Congress

    Impact of BKV Subtype Distribution on BKV Nephropathy, Viremia, and Renal Outcome in Patients After Renal Transplantation.

    S. Anke,1 L. Silvia,1 H. Hermann,1 H. Albert,2 S. Corinna.2

    1Nephrology, Hannover Medical School, Hannover, Germany; 2Virology, Hannover Medical School, Hannover, Germany.

    Factors determining the course of BK viral (BKV) infection remain uncertain. We studied the role of BKV subtype distribution in BKV-infected patients after renal transplantation.-We…
  • 2016 American Transplant Congress

    Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis.

    M. Morton,1 R. Chinnadurai,1 S. Ahmed,2 A. Sharma,2 T. Dutt,2 S. Bhutani,1 H. Denley,1 T. Augustine,1 T. Goodship,3 N. Sheerin,3 M. Picton.1

    1Renal Transplant Unit, Manchester Royal Infirmary, Manchester, United Kingdom; 2Royal Liverpool Hospital, Liverpool, United Kingdom; 3Freeman Hospital, Newcastle, United Kingdom.

    Background Eculizumab (EZB) is approved by NHSE in the UK for prevention and managment of recurrent aHUS after kidney transplantation. Purpose We report aggressive recurrence…
  • 2016 American Transplant Congress

    Is There a Link Between Proteinuria and Increased FGF-23 Levels in Renal Transplant Patients.

    E. Tutal,1 S. Sezer,1 Z. Bal,1 B. Demirci,1 M. Haberal.2

    1Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey; 2General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey.

    Purpose: Fibroblast growth factor 23 (FGF23) has emerged as a risk factor for cardiovascular disease and mortality in renal transplant (RT) recipients. Post transplantation proteinuria…
  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences